MindMaze Therapeutics Holding SA (SIX:MMTX; previously: RELIEF THERAPEUTICS Holding SA) acquired all the shares of NeuroX Group SA against issuance of new MMTX shares to complete their business combination by way of reverse merger. The new MMTX shares started trading at the SIX on 15 December 2025.

VISCHER advised RELIEF on all Swiss legal and tax aspects of this transaction. The team was lead by Dr. Robert Bernet (Partner, Corporate/M&A and Banking & Finance) and comprised Dr. Peter Kühn (Counsel, Corporate/M&A and Banking & Finance), Thomas Steiner-Krizaj (Managing Associate, Corporate/M&A), Christian Schneiter (Managing Associate, Banking & Finance), Hannah Everett (Junior Associate, Corporate/M&A and Banking & Finance), Christoph Niederer (Partner, Tax) and Patrik Fisch (Managing Associate, Tax).

Author: Peter Kühn